Efficacy and safety comparison of basic fibroblast growth factor-related decapeptide 0.1% solution (bFGFrP) plus oral PUVA combination therapy with oral PUVA monotherapy in the treatment of vitiligo

    January 2023 in “ Journal of Cutaneous and Aesthetic Surgery ”
    Priti Sarma, ChitraShivanand Nayak, MahendraM Kura … Rahul Pathak
    Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer

    We don't know much about this study yet.

    Read the full study on doi.org →
    Discuss this study in the Community →

    Research cited in this study 1

    1. Update on skin repigmentation therapies in vitiligo Pigment Cell & Melanoma Research · 2008